ERC Horizon Europe 2021 Submission Dates
Review on ex vivo HSC gene therapy for Nature Rev Genetics
Educational Resource: New Horizons in the Management of ADA-SCID
Transparence : et la science ? Nos concitoyens et concitoyennes ont droit à l'intégrité scientifique
Prix Nobel de Chimie pour Emmanuelle Charpentier et Jennifer Doudna
CDTI invests together with Inveready Biotech III and EASO Ventures in VIVEbiotech, a biotechnology startup that develops and produces viral vectors to be applied in gene therapy
MeiraGtx announces positive data for their AAV-RPGR program to treat X-Linked retinitis pigmentosa
Academia developing medicines for rare diseases to receive free EMA scientific advice
VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T™ cell therapy
Summary: SFTCG Theme Day on Viral Vectors
Déclaration de consensus des Sociétés Européennes de Thérapie Génique et Cellulaire sur la naissance annoncée de bébés génétiquement modifiés en Chine
Consensus statement of European Societies of Gene and Cell Therapy on the reported birth of genome-edited babies in China
Nouvelle vidéo de INSERM: Anne Galy explique CRISPR au grand public
Impressions du congrès de la SETGyC de Mallorca - Aurélie Mouka
Impressions du congrès de la SETGyC de Mallorca - Sébastien Riquier
Marche pour les Sciences: Texte à diffuser par les sociétés savantes à leurs adhérents
GSK receives positive CHMP opinion in Europe for StrimvelisTM, the first gene therapy to treat very rare disease, ADA-SCID
New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome
First stem-cell therapy recommended for approval in EU
12th stem cell clonality and genome stability retreat
Watch "A Gala for Our Time" an amfAR fundraising event for AIDS research
Rocket organises a virtual expert panel series each Friday in February in honour of Rare Disease Day.
Staff Scientist position in the SR-Tiget Process Development Laboratory
Pfizer Global Medical Grants (GMG)
Several job offers in Paris at the ICM - NeuroGenCell